Hongsong Chen

2.7k total citations
111 papers, 1.9k citations indexed

About

Hongsong Chen is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Hongsong Chen has authored 111 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hepatology, 38 papers in Epidemiology and 31 papers in Molecular Biology. Recurrent topics in Hongsong Chen's work include Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis C virus research (18 papers). Hongsong Chen is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis C virus research (18 papers). Hongsong Chen collaborates with scholars based in China, United States and Hong Kong. Hongsong Chen's co-authors include Lai Wei, Xingwang Xie, Ran Fei, Henghui Zhang, Cong Xu, Xueyan Wang, Dongbo Chen, Gaixia He, Jinxue Zhou and Yanhui Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Hongsong Chen

100 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongsong Chen China 23 767 544 490 436 387 111 1.9k
Cathal Harmon Ireland 15 461 0.6× 823 1.5× 374 0.8× 269 0.6× 373 1.0× 21 1.8k
Gangqiao Zhou China 26 1.2k 1.6× 441 0.8× 363 0.7× 227 0.5× 602 1.6× 82 2.4k
Guangfu Li United States 28 984 1.3× 644 1.2× 252 0.5× 216 0.5× 821 2.1× 96 2.4k
Adrian Keogh Switzerland 26 701 0.9× 221 0.4× 532 1.1× 565 1.3× 233 0.6× 55 1.8k
Shaogui Wan China 23 709 0.9× 254 0.5× 267 0.5× 201 0.5× 263 0.7× 62 1.5k
Handong Wei China 23 1.0k 1.4× 192 0.4× 310 0.6× 287 0.7× 200 0.5× 52 1.7k
Keng‐Hsin Lan Taiwan 33 1.4k 1.8× 502 0.9× 1.1k 2.3× 1.2k 2.8× 753 1.9× 129 3.7k
G P Jahreis United States 21 796 1.0× 482 0.9× 298 0.6× 156 0.4× 403 1.0× 29 2.0k
Wen Yuan Chung United Kingdom 18 567 0.7× 173 0.3× 198 0.4× 240 0.6× 289 0.7× 60 1.5k
Carmine Mancone Italy 25 1.7k 2.2× 185 0.3× 292 0.6× 341 0.8× 282 0.7× 55 2.5k

Countries citing papers authored by Hongsong Chen

Since Specialization
Citations

This map shows the geographic impact of Hongsong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongsong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongsong Chen more than expected).

Fields of papers citing papers by Hongsong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongsong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongsong Chen. The network helps show where Hongsong Chen may publish in the future.

Co-authorship network of co-authors of Hongsong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hongsong Chen. A scholar is included among the top collaborators of Hongsong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongsong Chen. Hongsong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yuting, Xinxin Wang, Zhengwei Liu, et al.. (2025). Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD. Bioorganic Chemistry. 157. 108245–108245. 3 indexed citations
2.
Zhao, Zhou, Xinyu Du, Yukun Li, et al.. (2025). Novel Function of NUP153 in HNF4α Transcriptional Upregulation Contributes to Promoting HBV Replication. Journal of Medical Virology. 97(3). e70256–e70256. 1 indexed citations
3.
Wang, Chong, Hongsong Chen, Zhenmin Liu, et al.. (2025). From cause to relief: Vitamin D plays a crucial role in overactive bladder via the RhoA/ROCK signaling pathway. Biochemical and Biophysical Research Communications. 766. 151919–151919.
4.
Zhang, Runling, Haiying Zhang, Zhang Li, et al.. (2025). Clinical indications and Z-score-assisted NIPT testing: a new perspective in prenatal screening. SHILAP Revista de lepidopterología. 5(1). e000187–e000187.
5.
Zhang, Zhicheng, Qiang Zhang, Chong Wang, et al.. (2024). Rab25 is involved in hypospadias via the β1 integrin/EGFR pathway. Experimental Cell Research. 436(2). 113980–113980. 3 indexed citations
7.
Liu, Xin, Ting Zhang, Hui Liu, et al.. (2024). Precore mutation enhances viral replication to facilitate persistent infection especially in HBeAg-negative patients. Virologica Sinica. 39(2). 319–330. 4 indexed citations
8.
Chen, Hongsong, Jing Mi, Sen Li, et al.. (2023). Design, synthesis and evaluation of quinoline- O -carbamate derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2169682–2169682. 25 indexed citations
9.
Wang, Zilong, et al.. (2023). Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World Journal of Hepatology. 15(6). 813–825. 2 indexed citations
11.
Zhang, Haiying, Ying Ji, Cong Xu, et al.. (2022). Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients. Frontiers in Microbiology. 13. 816778–816778. 15 indexed citations
12.
Fan, Rong, Chao Qiu, Ruru Deng, et al.. (2022). [Expert consensus on measurement and clinical application of serum HBV RNA in patients with chronic HBV infection].. PubMed. 30(5). 505–512. 1 indexed citations
13.
14.
Zhao, Wensi, Wanpu Yan, Dongbo Chen, et al.. (2019). Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.. PubMed Central. 9(6). 1183–1200. 24 indexed citations
15.
Zhao, Yangjing, Yanhui Chen, Ying Hu, et al.. (2018). Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing. Translational Cancer Research. 7(2). 231–239. 5 indexed citations
16.
Wang, Yan, Henghui Zhang, Yanhui Chen, et al.. (2012). [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma].. PubMed. 46(6). 527–32. 5 indexed citations
17.
Zhang, Henghui, Huiying Rao, Dong Jiang, et al.. (2012). DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response. PLoS ONE. 7(6). e38390–e38390. 12 indexed citations
18.
Wang, Yan, Lai Wei, Dong Jiang, et al.. (2007). In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation. Antiviral Research. 75(2). 139–145. 13 indexed citations
19.
Zhang, Henghui, et al.. (2007). The Functional Evaluation of Dendritic Cell Vaccines Based on Different Hepatitis C Virus Nonstructural Genes. Viral Immunology. 20(4). 553–561. 9 indexed citations
20.
Chen, Dongshu, Jian‐Chuan Xia, Yasuhiro Tanaka, et al.. (2003). Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1‐positive carcinoma cells. Immunology. 109(2). 300–307. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026